Cover Image
市場調查報告書

息肉狀脈絡膜血管病變:全球臨床實驗趨勢

Polypoidal Choroidal Vasculopathy Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 339394
出版日期 內容資訊 英文 76 Pages
訂單完成後即時交付
價格
Back to Top
息肉狀脈絡膜血管病變:全球臨床實驗趨勢 Polypoidal Choroidal Vasculopathy Global Clinical Trials Review, H2, 2015
出版日期: 2015年07月31日 內容資訊: 英文 76 Pages
簡介

本報告提供息肉狀脈絡膜血管病變臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,並彙整有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 息肉狀脈絡膜血管病變
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:眼科疾病治療藥臨床實驗上息肉狀脈絡膜血管病變的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病治療藥臨床實驗上息肉狀脈絡膜血管病變的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標的達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

息肉狀脈絡膜血管病變治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Bayer AG
    • Regeneron Pharmaceuticals, Inc.
    • Novartis AG
    • Hawaii Pacific Health
    • Pfizer Inc.
    • OXiGENE, Inc.
    • Oraya Therapeutics, Inc.
    • Ophthotech Corp.
    • Lpath, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Southeast Retina Center
    • Asan Medical Center
    • Federal University of Sao Paulo
    • 兵庫醫科大學
    • 香川大學
    • Kyungpook National University
    • La Fondation Ophtalmologique Adolphe de Rothschild
    • Manhattan Eye Ear & Throat Hospital
    • Medizinische Universitat Wien
    • 日本大學

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2797CTIDB

GlobalData's clinical trial report, "Polypoidal Choroidal Vasculopathy Global Clinical Trials Review, H2, 2015" provides an overview of Polypoidal Choroidal Vasculopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Polypoidal Choroidal Vasculopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Polypoidal Choroidal Vasculopathy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Polypoidal Choroidal Vasculopathy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Regeneron Pharmaceuticals, Inc.
      • Clinical Trial Overview of Regeneron Pharmaceuticals, Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Hawaii Pacific Health
      • Clinical Trial Overview of Hawaii Pacific Health
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • OXiGENE, Inc.
      • Clinical Trial Overview of OXiGENE, Inc.
      • Oraya Therapeutics, Inc.
      • Clinical Trial Overview of Oraya Therapeutics, Inc.
      • Ophthotech Corp.
      • Clinical Trial Overview of Ophthotech Corp.
      • Lpath, Inc.
      • Clinical Trial Overview of Lpath, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Southeast Retina Center
      • Clinical Trial Overview of Southeast Retina Center
      • Asan Medical Center
      • Clinical Trial Overview of Asan Medical Center
      • Federal University of Sao Paulo
      • Clinical Trial Overview of Federal University of Sao Paulo
      • Hyogo College Of Medicine
      • Clinical Trial Overview of Hyogo College Of Medicine
      • Kagawa University
      • Clinical Trial Overview of Kagawa University
      • Kyungpook National University
      • Clinical Trial Overview of Kyungpook National University
      • La Fondation Ophtalmologique Adolphe de Rothschild
      • Clinical Trial Overview of La Fondation Ophtalmologique Adolphe de Rothschild
      • Manhattan Eye Ear & Throat Hospital
      • Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital
      • Medizinische Universitat Wien
      • Clinical Trial Overview of Medizinische Universitat Wien
      • Nihon University
      • Clinical Trial Overview of Nihon University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Region, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Polypoidal Choroidal Vasculopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hawaii Pacific Health, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by OXiGENE, Inc., 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Oraya Therapeutics, Inc., 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ophthotech Corp., 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Lpath, Inc., 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeast Retina Center, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kagawa University, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyungpook National University, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by La Fondation Ophtalmologique Adolphe de Rothschild, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medizinische Universitat Wien, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nihon University, 2015*

List of Figures

  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Polypoidal Choroidal Vasculopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top